Sleep Apnea Testing and Management in Patients With Atrial Fibrillation: Why is it So Difficult?
Sleep Apnea Testing and Management in Patients With Atrial Fibrillation: Why is it So Difficult? J Cardiovasc Nurs. 2020 Jul/Aug;35(4):324-326 Authors: Desteghe L, Linz D, Hendriks JM PMID: 32541607 [PubMed - in process]
Publication date: Available online 10 October 2020Source: IJC Heart &VasculatureAuthor(s): Dominik Linz, Jeroen Hendriks
Condition: Sleep Deprivation Intervention: Behavioral: Moderate intensity interval training (MITT) Sponsors: Cairo University; National Heart Institute, Egypt Completed
Publication date: Available online 4 September 2020Source: IJC Heart &VasculatureAuthor(s): Anna M. May, Lu Wang, Deborah H. Kwon, David R. Van Wagoner, Mina K. Chung, Jarrod E. Dalton, Reena Mehra
AbstractIncreasingly compelling data link chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) to cardiovascular complications independent of known comorbidities. It remains unclear whether the association is amplified in the presence of both conditions. The aims of this study are to assess the prevalence of atrial fibrillation (AF) in overlap syndrome (OS) and to identify risk factors predisposing to this atrial arrhythmia. We conducted a retrospective cohort study of 268 adults without past or current AF who were referred for an initial diagnostic polysomnogram from 2012 to 2019. A logistic regr...
Atrial fibrillation (afib) is a common heart rhythm disorder in which the upper chambers of the heart (the atria) beat fast and irregularly. Afib commonly causes recurrent symptoms, usually palpitations and shortness of breath, and can negatively affect quality of life. Afib also substantially increases the risk of stroke, and is also associated with heart failure, high blood pressure, and diabetes. People with afib routinely require lifelong treatment with blood thinners, to prevent blood clots that can lead to strokes. Doctors are only recently understanding the importance of lifestyle factors in treating afib. Modifiabl...
In this issue of International Journal of Cardiology, Weinmann et al. investigated the impact of overweight and obesity in 600 patients who underwent cryoballoon pulmonary vein (PV) isolation for atrial fibrillation (AF) on procedural characteristics and clinical outcomes . Compared to patients that classified as normal, obese patients suffered more frequently from hypertension, diabetes mellitus, obstructive sleep apnea, and exhibited larger left atrial dimensions. No significant differences were found in complication rates between normal weight patients and overweight or obese patients.
We describe the various pharmacological and non-pharmacological strategies for AF management with a peek at some futuristic approaches. While each one of these variables could lend themselves for a separate review, we attempted to provide an overview of the most critical predictors of AF outcomes to equip the readers with the latest know-how of the management of AF.
I’ve been wearing my Fitbit for a couple of years and only remove it when I shower. I use it to track my sleep and its smart alarm wakes me up at the optimal time every morning. With the pocketable Kardia, I regularly check my ECG at home to detect any anomalies. For an in-depth analysis of what my genetic makeup predisposes me to, I had my whole genome sequenced. And I bring relevant data to my general practitioner during my checkups so that we can decide on preventive measures. In short, I’m trying to live like the patient of the future. However, posing as such a patient is not feasible for many among us. ...
A 66-YEAR-old man with a history of hypertension, hyperlipidemia, obstructive sleep apnea, coronary artery disease, atrial fibrillation on anticoagulation, and mitral valve prolapse with severe mitral regurgitation, was referred to the authors ’ institution for coronary artery bypass grafting (CABG), mitral valve repair, and Maze cryoablation. Preoperative transesophageal echocardiography (TEE) showed normal biventricular function with a mildly dilated left ventricle, severely dilated left atrium, and flail posterior mitral valve leafle t (P2 and P3 segments) with severe mitral regurgitation.